Comprehensive Strategies for Preoperative Pulmonary Risk Evaluation and Management

Hyo Jin Lee; Hyun Woo Lee

doi:10.4046/trd.2024.0118

Tuberc Respir Dis > Volume 88(1); 2025 > Article

Lee and Lee: Comprehensive Strategies for Preoperative Pulmonary Risk Evaluation and Management

Review

Miscellaneous

Tuberculosis and Respiratory Diseases 2025;88(1):90-108.

Published online: October 30, 2024

DOI: https://doi.org/10.4046/trd.2024.0118

Comprehensive Strategies for Preoperative Pulmonary Risk Evaluation and Management

Hyo Jin Lee, M.D.

, Hyun Woo Lee, M.D.

Division of Respiratory and Critical Care, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Republic of Korea

Address for correspondence Hyun Woo Lee, M.D. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Republic of Korea E-mail athrunzara86@snu.ac.kr

Received August 7, 2024 Revised October 10, 2024 Accepted October 28, 2024

It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).

Abstract

Postoperative pulmonary complications (PPCs) significantly increase morbidity and mortality in surgical patients, particularly those with pulmonary conditions. PPC incidence varies widely, influenced by factors such as surgery type, patient age, smoking status, and comorbid conditions, including chronic obstructive pulmonary disease (COPD) and congestive heart failure. While preoperative pulmonary function tests and chest radiographs are crucial for lung resection surgery, their use should be judiciously tailored to individual risk profiles. Effective risk stratification models, such as the American Society of Anesthesiologists classification, Arozullah respiratory failure index, Gupta Calculators, and Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) model, play a key role in predicting PPCs. Key strategies to diminish PPCs include preoperative optimization of respiratory conditions, smoking cessation, and respiratory rehabilitation. In patients with COPD and asthma, it is crucial to maintain optimal disease control through inhaled therapies, systemic corticosteroids, and tailored preoperative respiratory exercises. Anemia and hypoalbuminemia are significant predictors of PPCs and require meticulous management. The choice and duration of anesthesia also notably influence PPC risk, with regional anesthesia being preferable to general anesthesia when possible. Comprehensive preoperative evaluations and tailored interventions are essential for enhancing surgical outcomes and reducing PPC incidence. Additional studies involving domestic patients are necessary to refine national guidelines for managing those at risk of PPCs.

Keywords: Postoperative Complications; Pulmonary Disease; Preoperative Care; Risk Assessment; Smoking Cessation; Respiratory Function Tests

Key Figure

Introduction

Postoperative pulmonary complications (PPCs) are frequent and contribute significantly to increased morbidity and mortality following surgical procedures, especially in patients with pre-existing pulmonary conditions [1]. PPCs are as common as cardiac complications and are potentially more indicative of long-term postoperative mortality, particularly in elderly patients [2]. Moreover, PPCs extend intensive care unit (ICU) stays due to the need for mechanical ventilation and influence readmission rates post-discharge, thereby increasing healthcare costs [3,4]. Therefore, accurately stratifying the risk of PPCs and implementing effective strategies to mitigate these risks are crucial for enhancing patient outcomes. This article will focus on key clinical factors and strategies aimed at reducing PPCs in surgical patients.

Definition

Although there is no unanimous agreement, the definition of PPCs typically encompasses a broad range of respiratory conditions that can either extend hospital stays or contribute to morbidity and mortality. PPCs are categorized as either major or minor, depending on their potential impact on mortality [5]. PPCs include major complications such as respiratory failure, mechanical ventilation lasting more than 48 hours, and pneumonia; and minor complications such as purulent tracheobronchitis, atelectasis, and bronchospasm. In 2015, a European joint task force published guidelines outlining definitions for European Perioperative Clinical Outcome, which include recommended definitions for PPCs as presented in Table 1 [6,7].

The severity classification of PPCs consists of four grades [8]: grade 1, minor risk events that do not require therapy; grade 2, potentially life-threatening complications requiring intervention or a hospital stay more than twice the average, divided into grade 2a for medication-only treatment and grade 2b for invasive procedures; grade 3, complications causing lasting disability or organ resection; and grade 4, fatal outcomes resulting from a complication.

Epidemiology

Generally, the incidence of PPCs varies between 2% and 19%, a range that stems from differences in how PPCs are defined [5,9]. Reported incidences of these respiratory complications are approximately 1% to 2% in minor surgeries and 6% to 20% in upper abdominal surgeries, while thoracic surgeries [10,11] see rates of 14.5% to 25%. Roughly 10% to 30% of patients requiring general anesthesia are at risk of PPCs, which are clinically more significant than other complications such as postoperative thromboembolism, cardiovascular issues, or infections [12,13]. Notably, up to 90% of patients experience some degree of atelectasis during anesthesia, influenced by factors such as patient positioning and decreased functional residual capacity [14]. Although the overall risk of severe PPCs, including acute respiratory distress syndrome, remains low at 0.2%, this risk increases in patients with comorbid conditions such as renal failure, chronic obstructive pulmonary disease (COPD), emergency surgeries, or multiple anesthesia exposures [15].

Patient-Related Risk Factors

A comprehensive evaluation of a patient’s medical history and physical examination is crucial in assessing the risk of PPCs. Key patient-related risk factors for PPCs include advanced age, an American Society of Anesthesiologists (ASA) category of ≥2, functional limitations, hypoalbuminemia, current smoking status, and the presence of comorbid conditions such as COPD or congestive heart failure [16,17].

1. Age

Age is a significant independent predictor of surgical complications. Individuals aged ≥50 years have a greater risk of experiencing PPCs, and this risk increases 5-fold upon reaching ≥80 years [16,18].

2. Smoking

Smoking significantly enhances PPC risk. Current smokers have a higher incidence of PPCs compared to ex-smokers and non-smokers, with the risk increasing in correlation with pack-years smoked: adjusted odds ratios (ORs) are 1.20 for <20 pack-years, 1.57 for 41-60 pack-years, and 1.82 for >60 pack-years [19]. Smoking cessation significantly lowers the risk of PPCs; cessation for over 4 weeks reduces PPCs by 23% and over 8 weeks by 47% [19]. The 30-day post-surgery mortality rate is increased among current smokers (OR, 1.17), but not among ex-smokers or non-smokers [20].

3. Functional status

Functional or overall health status is another crucial predictor of PPCs. The ASA classification, which assesses chronic illnesses, comorbid conditions, and clinical acuity, correlates with enhanced PPCs risk; an ASA class ≥2 is associated with a substantial OR of 4.87 [16,21]. Patients with neuromuscular weakness also face an increased PPC risk due to increased propensity for hypoventilation and impaired cough [22]. Pooled analyses indicate that individuals with partial or total physical dependence are more likely to suffer from postoperative respiratory failure and pneumonia [23].

4. Obesity

Obesity can induce restrictive physiology and is known to reduce lung volumes in the perioperative setting. A retrospective cohort study demonstrated that in obese individuals (body mass index ≥25 kg/m²), a restrictive spirometry pattern was linked to a 4.3-fold increased risk of PPCs, in contrast to the non-obese group where there was no increased risk [24]. While retrospective studies and pooled analyses of small cohorts showed no significant association between obesity and an increased risk of postsurgical complications [25], larger cohort studies reported a higher incidence of PPCs among obese patients [26].

5. Cardiac comorbidity

Specific comorbidities significantly contribute to the risk of PPCs. Congestive heart failure, for example, has been consistently identified as a strong predictor of postoperative respiratory failure in multiple studies [23]. Other cardiac risk factors linked to PPCs include right atrial enlargement, pericardial effusion, the degree of leftward septal shift observed on a transthoracic echocardiogram, and right axis deviation on echocardiogram [5].

6. Pulmonary comorbidity

COPD is widely recognized as an independent risk factor for PPCs, irrespective of whether the surgery is thoracic or non-thoracic [27]. Comprehensive multivariate analyses have shown that COPD is associated with an increased risk of various postoperative complications, including pneumonia, respiratory failure, myocardial infarction, cardiac arrest, sepsis, the necessity for a return to the operating room, renal insufficiency or failure, and wound dehiscence [28].

Although interstitial lung diseases (ILDs) are associated with adverse respiratory events, the literature still presents controversial results. General anesthesia and mechanical ventilation may increase the risk of exacerbating the inflammatory process in fibrotic parenchymal diseases and promote adult respiratory distress syndrome [29]. However, performing an elective surgical lung biopsy for ILD is considered relatively safe and manageable, given the benefits and risks of the surgery [30].

Surgery-Related Risk Factors

1. Non-thoracic surgery

Being closer to the diaphragm serves as a predisposing factor, increasing the incidence of PPCs [31]. It is essential to consider the surgical site, as its proximity to the respiratory system significantly influences the likelihood of respiratory failure [32]. Aortic and thoracic surgeries carry the highest risk, followed by upper abdominal and neurosurgical procedures when assessing postoperative pneumonia and respiratory failure [33]. Additionally, the urgency level of non-thoracic surgery is crucial, as urgent or emergent procedures are associated with roughly a 2-fold increased risk of PPCs [34].

2. Lung surgery

The European Thoracic Surgery Database project, analyzing 3,426 patients, identified dyspnea severity, ASA score, procedural class, and age as independent contributors to in-hospital mortality after lung resection, despite a low overall rate of 2% [35]. Laboratory test results indicated that preoperative fibrinogen and lactate dehydrogenase levels were linked to increased perioperative morbidity [11]. Further investigations revealed correlations between the extent of the tumor or surgical lung resection and higher morbidity risks [35].

3. Cardiac surgery

Underlying lung disease is associated with increased PPCs, arrhythmias, and higher mortality following cardiac surgery [36]. This association can be attributed to altered lung and chest wall mechanics following sternotomy [37], effects of cardiopulmonary bypass, and potential phrenic nerve thermal injury [38]. However, severe airflow limitation or functional impairment should not be considered an absolute contraindication for cardiac surgery, given the long-term benefits observed in these patients [39].

4. Esophagectomy

Esophagectomy is associated with a high risk of PPCs. A multicenter study involving 1,777 patients who underwent esophageal resection reported a pneumonia incidence of 21% and a respiratory failure incidence of 16% [40]. Additionally, a randomized trial involving 220 patients with adenocarcinoma found that the trans-hiatal approach significantly reduced the incidence of PPCs compared to the transthoracic approach (27% vs. 57%, p<0.001) [41].

5. Duration of surgery

Surgery lasting 2 hours or more has been shown to double the risk of PPCs [3,42]. Several prospective studies have also indicated that the duration of general anesthesia, especially in surgeries exceeding 2 hours, is linked to an approximately 3-fold increase in the risk of PPCs [43].

6. Type of anesthesia

Strategic planning in anesthesia management during surgical procedures is critical, due to the well-established correlation between the type of anesthesia used and the incidence of PPCs [23,33,43]. General anesthesia is associated with higher rates of respiratory failure and postoperative pneumonia compared to neuraxial anesthesia [44]. In patients with COPD, the use of general anesthesia significantly increases the risk of PPCs, ventilator dependence, and unplanned postoperative intubations compared to regional anesthesia [45]. Therefore, whenever possible, neuraxial or regional anesthesia should be preferred over general anesthesia [46].

During general anesthesia, to prevent barotrauma from volume-control ventilation, pressure-control ventilation is preferred. Excessive ventilation may lead to alkalosis [47], exacerbate bronchoconstriction, or provoke cardiovascular complications [48]. Moreover, a decrease rather than an increase in tidal volume [49], reduced compliance [50], increased mechanical power [51], and reduced end-tidal carbon dioxide have been independently linked to PPCs [51]. Mechanical hypoventilation may be beneficial, yet hypoxemia should be avoided [52].

During general anesthesia, inhaled anesthetics can impair surfactant function and alter the oxygen-to-nitric oxide ratio. This alteration potentially increases gas reabsorption and contributes to the development of atelectasis [53]. Additionally, the use of neuromuscular blockers reduces respiratory muscle strength for several days [54]. Intermediate and long-acting neuromuscular blockers are linked to postoperative complications including atelectasis, re-intubation, pneumonia, and pulmonary edema [55]. A prospective study showed a dose-dependent increase in the incidence of postoperative pneumonia and respiratory failure associated with these neuromuscular blockers [55]. Unfortunately, neither continuous intraoperative neuromuscular monitoring nor the use of reversal agents effectively reduce the risk of PPCs [56].

Preoperative Assessment for Postoperative Pulmonary Complications

1. Pulmonary function test

Pulmonary function tests (PFTs) are essential for preoperative assessment in lung surgery, as predicted postoperative (ppo) lung function correlates strongly with PPCs. Particularly, low forced expiratory volume in 1 second (FEV₁) or diffusing capacity of the lungs for carbon monoxide (DL_CO) is significantly associated with complicated postoperative courses and poor surgical outcomes in patients undergoing lung resections [57]. Notably, the percentage of predicted values for FEV₁ and DL_CO is more indicative of PPCs than their absolute values [58].

In the context of non-thoracic surgery, routine preoperative pulmonary function testing does not significantly reduce the incidence of PPCs [59]. The association between impaired lung function and increased risk of PPCs in non-thoracic surgery remains contentious. Although several cohort studies have indicated that lower FEV₁ or forced vital capacity (FVC) correlates with an increased risk of PPCs in patients undergoing non-thoracic surgery [59], comparisons of lung function between patients with and without PPCs reveal no substantial differences among those with obstructive lung patterns [60]. These results imply that underlying pulmonary conditions, rather than lung function per se, are main determinants of PPC risk. Hence, preoperative PFTs should be reserved for cases with a strong suspicion of underlying pulmonary conditions. The previous guidelines on preoperative PFTs are outlined in Table 2.

2. Chest radiographs

Routine preoperative chest X-rays do not reduce the incidence of PPCs. A systematic review found that the occurrence of PPCs was unaffected by whether a preoperative chest X-ray had been performed [61]. Even when abnormalities were detected, they had no significant effect on the frequency of PPCs [61]. Indeed, the influence of chest X-ray findings on preoperative management is negligible. One systematic review revealed that although 10% of preoperative chest X-rays demonstrated abnormalities, only 1.3% uncovered unexpected results, and a mere 0.1% affected management decisions [62]. In a large prospective study, 23% of chest X-rays exhibited abnormalities, yet only 1.1% led to modifications in management [63]. Consequently, preoperative chest X-rays should be reserved for cases with a strong suspicion of underlying pulmonary conditions that might influence the management plan. Summaries of previous guidelines on preoperative chest X-rays can be found in Table 2 [64-67].

3. Blood tests

Anemia is a significant risk factor for PPCs. The underlying pathophysiological mechanisms involve impaired oxygen delivery to tissues and diminished immune function, contributing to postoperative hypoxemia, respiratory infections, and other pulmonary issues. Untreated preoperative anemia, with a prevalence exceeding 30% in non-cardiac surgeries and higher in elderly patients, is associated with an increased risk of adverse surgical outcomes [68]. Additionally, the presence of anemia and the use of allogeneic blood transfusions individually correlate with a higher risk of PPCs and surgical site infections [69]. Even mild anemia, characterized by hemoglobin levels below 13 g/dL in males and below 12 g/dL in females, is associated with increased risks of adverse perioperative outcomes [70]. Although thorough evaluation and management of anemia are advocated, there is no evidence suggesting that preoperative red blood cell (RBC) transfusions reduce PPCs. Thus, preoperative RBC transfusions should be reserved for situations such as emergent surgery or life-threatening anemia.

Hypoalbuminemia is acknowledged as a significant predictor of increased PPC risk [16]. In cases of hypoalbuminemia, patients display poor nutritional status, which impairs immune function and reduces tissue repair capabilities. Although definitions of hypoalbuminemia vary, it is typically characterized by serum albumin levels below 20-40 g/L. OR for hypoalbuminemia range from 1.5 to 2.5 for PPCs, with lower serum levels corresponding to higher risks [71]. Despite the association, there is no present evidence supporting the effectiveness of albumin replacement or nutritional interventions in elevating serum albumin levels to reduce PPC risk.

Risk Stratification of Postoperative Pulmonary Complications

Various prediction models for PPCs have been developed, including the Arozullah respiratory failure risk index, Gupta risk calculators, and Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) model [72,73]. The key factors in each prediction model for PPCs are summarized in Table 3.

1. ASA classification

The ASA classification, a commonly employed system, subjectively assesses and categorizes patients’ preoperative physical status. While it initially aimed to predict perioperative mortality, it has also been validated as a predictor of PPCs. A significant association has been reported between higher ASA classifications and an increased risk of PPCs; specifically, an ASA class of II or higher is associated with a substantially elevated risk (OR, 4.87; 95% confidence interval [CI], 3.34 to 7.10) compared to ASA class I. Furthermore, the risk increases when comparing ASA class III or higher to classes below III (OR, 2.25; 95% CI, 1.73 to 3.76) [74].

2. Arozullah respiratory failure index

The Arozullah respiratory failure index identified seven independent factors—type of surgery, emergency surgery, albumin, blood urea nitrogen, functional status, COPD, and age—that are associated with postoperative respiratory failure. Point scores based on their association strength in multivariate analysis are assigned, stratifying patients into five classes with respiratory failure rates ranging from 0.5% to 26.6% [75]. The predictive performance was assessed with a c-statistic of 0.828 in a validated cohort [23].

3. Gupta calculator for postoperative respiratory failure and pneumonia

The Gupta calculator for postoperative respiratory failure utilizes five preoperative factors (type of surgery, emergency surgery, functional status, preoperative sepsis, and ASA class) to predict the risk of postoperative respiratory failure [76]. It calculates a probability percentage of postoperative respiratory failure using the logistic regression equation e^x/(1+e^x)-1.7397, where x is the sum of the coefficients of the variables in the multivariable model. The predictive performance of this model was assessed, yielding a c-statistic of 0.897 in a validated cohort.

The Gupta calculator for postoperative pneumonia was constructed similarly to the respiratory failure calculator [77]. It incorporates seven preoperative factors (age, ASA class, COPD, functional status, preoperative sepsis, smoking status, and type of surgery) to formulate the likelihood of postoperative pneumonia. It generates a probability percentage of postoperative pneumonia using the equation e^x/(1+e^x)-2.8977, where x is derived from the sum of the variable coefficients in the multivariable model. The predictive performance of this model was validated with a c-statistic of 0.860 in a cohort.

4. ARISCAT

The ARISCAT model includes seven preoperative risk factors (age, oxygen saturation [SpO₂], recent history of respiratory infection, anemia, type of surgery, duration of surgery, and emergency surgery) for estimating the likelihood of PPCs [31,43]. It transforms beta-coefficients into a risk score, categorizing individuals as low risk if they score below 26 points, high risk if they score 45 points or above, and intermediate risk for scores in between. PPC probabilities were 1.6% in the low-risk group, 13.3% in the intermediate-risk group, and 42.1% in the high-risk group. The predictive accuracy of the ARISCAT model was assessed with a c-statistic of 0.88 in a validated cohort [43].

Preoperative Pulmonary Assessments

1. Non-thoracic surgery

In patients at risk of PPCs, an evaluation for respiratory symptoms, smoking history, occupational history, recent respiratory infections, or underlying chronic lung disease is recommended. Before undergoing non-thoracic surgery, chest X-rays and PFTs are necessary if there are respiratory symptoms indicative of respiratory disease (Figure 1) [78]. Even in individuals without a history of lung disease or respiratory symptoms, smokers should refrain from smoking for 2 to 4 weeks preoperatively. Additionally, the implementation of incentive spirometry and postoperative breathing exercises should be actively considered.

2. Lung resection surgery

In patients undergoing lung resection surgery, calculating their ppo FEV₁ and DL_CO is essential. Various studies have evaluated postoperative pulmonary function at different time points following lobectomy or pneumonectomy [79]. Results showed that FEV₁ achieved 84% to 91% of preoperative values after lobectomy and 64% to 66% after pneumonectomy. DL_CO registered 89% to 96% of preoperative values post-lobectomy and 72% to 80% post-pneumonectomy. Maximal oxygen consumption (VO₂max) measurements indicated a recovery to 87% to 100% of preoperative levels post-lobectomy and 71% to 89% post-pneumonectomy.

Across studies involving more than 2,000 patients from three large datasets in the 1970s, a mortality rate under 5% was observed when the preoperative FEV₁ exceeded 2 L for pneumonectomy and 1.5 L for lobectomy [80]. According to standard guidelines, pneumonectomy is deemed suitable if the preoperative FEV₁ is over 2 L, and lobectomy if the FEV₁ exceeds 1.5 L [80]. Moreover, if the patient exhibits no dyspnea on exertion or ILD, an FEV₁ above 80% of the predicted value or more than 2 L is considered sufficient for pneumonectomy without further physiological evaluation, while an FEV₁ exceeding 1.5 L is suitable for lobectomy without additional assessments [80].

However, studies have indicated that the percentage of the normal predicted value, rather than absolute values, is more predictive of patient risk and outcomes following surgery [58]. The 2009 European Respiratory Society guidelines suggest that if the percent ppo FEV₁ and ppo FVC exceed 80%, the patient is considered at low risk for complications following lung resection [81]. According to the 2013 American College of Chest Physicians guidelines, patients with ppo FEV₁ and ppo FVC greater than 60% are considered at low risk for postoperative complications (Figure 2) [82]. Patients not categorized as low risk, but with ppo FEV₁ above 30%, should have their exercise capacity assessed through validated tests such as stair climbing or shuttle walk tests. For those with a ppo FEV₁ less than 30% or poor exercise capacity, a cardiopulmonary exercise test should be conducted. If the VO₂max is below 10 mL/kg/min or less than 35% of the predicted value, surgery should be avoided due to the high risk of complications.

General Preoperative Management

Preoperative management includes advocating for smoking cessation, managing COPD and asthma, managing respiratory tract infections, and incorporating techniques from respiratory physiotherapy (Figure 3). These components collectively contribute to reducing postoperative complications and improving the overall health of the patient.

1. Smoking cessation

Preoperative smoking cessation is highly encouraged for current smokers, as it significantly reduces the risk of PPCs, especially if cessation occurs more than 8 weeks prior to surgery [19]. Although previously uncertain, recent studies indicate that cessation periods shorter than 8 weeks can also be beneficial. A systematic review of 25 studies found that abstaining from smoking for at least 3 to 4 weeks before surgery can decrease the incidence of respiratory and wound-healing complications [83]. Therefore, it is crucial for current smokers to receive clear counseling on the risks associated with smoking and the advantages of cessation before undergoing surgery.

2. Respiratory tract infections

Given that airway inflammation may persist after the resolution of an infectious pathogen, it is advisable to postpone elective surgery for approximately 6 weeks in patients who have recently experienced a respiratory tract infection. While most studies on preoperative respiratory infections focus on the upper respiratory tract, fewer studies have examined the consequences of lower respiratory tract infections. However, existing evidence suggests that preoperative pneumonia is linked to increased postsurgical mortality [84], and heightened postoperative morbidity [84].

3. Respiratory rehabilitation

Postoperative changes in lung volumes, respiratory muscle function, mucociliary clearance, and inadequate pain management in respiratory muscles are primary factors causing PPCs, including pneumonia and severe atelectasis [6]. Current studies are focusing on interventions designed to improve respiratory function, such as incentive spirometry, deep breathing exercises, physiotherapy, and inspiratory muscle training [85]. All lung expansion techniques appear effective in reducing the incidence of PPCs, although the specific effectiveness of incentive spirometry remains uncertain. A single 30-minute preoperative physiotherapy session has been demonstrated to significantly reduce the occurrence of PPCs, including atelectasis observed on chest radiographs, in patients undergoing upper abdominal surgery [86]. Inspiratory muscle training usually involves five to seven supervised sessions per week, each lasting 15 to 30 minutes, for 2 weeks before surgery. This regimen may be halted if postoperative pain or other symptoms hinder participation. A Cochrane review, involving 695 patients across 12 studies, indicated that preoperative inspiratory muscle training significantly reduced rates of postoperative atelectasis and pneumonia, and also shortened the duration of hospital stays following cardiac and major abdominal surgeries [87].

Disease-Specific Preoperative Evaluation and Management

1. COPD

1) Evaluation

The initial step in the preoperative evaluation of COPD is to confirm the diagnosis using post-bronchodilator spirometry in patients with risk factors for COPD and chronic respiratory symptoms indicative of the disease. Once diagnosing COPD, it is vital to determine if the condition is well-controlled. This involves evaluating the patient’s current symptom status and conducting a physical examination to identify findings such as diminished breath sounds or wheezing. If there is an acute worsening of symptoms or the presence of wheezing, patients should use bronchodilators and may require systemic corticosteroids before undergoing surgery. Additionally, it is essential to actively search for signs of an ongoing respiratory infection, including fever, purulent sputum, aggravated cough, or dyspnea. If any of these symptoms are identified, whenever feasible, surgical procedures should be postponed, and appropriate antibiotic treatment should be initiated before surgery.

Additionally, it is essential to verify that patients are managed according to current treatment guidelines, which include regular inhaled therapy and pulmonary rehabilitation. Notably, recent randomized controlled trials have shown that adherence to pulmonary rehabilitation before surgery leads to improved exercise capacity, reduced hospital length of stay, and decreased 90-day mortality after surgery in stable COPD patients [88,89].

Preoperative pulmonary function testing is considered unnecessary for individuals with well-controlled COPD. Additionally, there are no well-defined criteria for contraindicating non-thoracic surgery based on PFTs in COPD patients. For lung resection surgery, the preoperative evaluation relies on the ppo lung function, following the previously described guidelines for lung resection surgery.

Arterial blood gas analysis is generally unnecessary in most situations. However, it is required for individuals with COPD at stages 3 and 4 undergoing major surgery or procedures lasting over 3 hours [16]. This is particularly critical when the FEV₁ is below 50% of the predicted value or in cases with a history of prior hypercapnia [16]. Arterial blood gas analysis plays a pivotal role in configuring the ventilator settings according to the patient’s baseline oxygen and carbon dioxide levels. Furthermore, it aids in assessing the need for postoperative oxygen therapy or mechanical ventilation.

Although routine chest X-ray is not generally recommended, it is necessary for patients with COPD, particularly those over 60 and undergoing significant abdominal or thoracic surgeries. Its necessity becomes apparent in the presence of acute respiratory symptoms, diminished exercise capacity, and altered auscultatory breath sounds. The test is valuable for identifying potential cases of pneumonia or heart failure [90].

2) Management

The algorithm for perioperative management of patients with COPD is outlined in Figure 4. Stable individuals should continue their medication regimen uninterrupted, even on the day of surgery. For symptomatic individuals undergoing major elective surgery, hospitalization three to 5 days prior to the procedure is advantageous. This period allows for the administration of intravenous corticosteroids and rapidly acting inhaled bronchodilators on a prescribed schedule [5].

Exacerbations may necessitate the use of corticosteroids, either alone or combined with antibiotics, which can lead to a recommended postponement of surgery. The duration of this postponement is tailored to the patient, extending until symptoms return to baseline levels. During this period, primary interventions typically involve the use of inhaled bronchodilators, muscarinic antagonists, short-term systemic steroids, and antibiotics [91].

Individuals prescribed prednisone for over 30 days or at a dose exceeding 20 mg for more than 2 weeks within the past year are at risk for postoperative adrenal insufficiency. In high-risk patients, diagnostic assessment prior to surgery is recommended; if time constrains, empirical administration of corticosteroids, such as 100 mg of hydrocortisone every 8 hours intravenously, is justified [92]. However, routine administration of stress-dose glucocorticoids is not recommended for patients using high doses of inhaled glucocorticoids [93].

2. Asthma

1) Evaluation

The preoperative evaluation for asthma entails assessing current control under existing treatment, performing laboratory tests, and identifying comorbidities [94]. Table 4 outlines the criteria for assessing asthma control. The evaluation should consider the patient’s daily activities and physical condition. It is crucial to assess for infectious symptoms, sputum characteristics and quantity, allergic status, triggers of exacerbation, and the current medication plan [52]. Additionally, documenting any history of emergency visits, hospitalizations, ICU admissions, and use of systemic corticosteroids before surgery is important [95].

The preoperative physical examination should include an assessment of respiratory rate and auscultation of both lung fields to identify signs of acute exacerbation, acute respiratory infection, chronic lung disease, and right heart failure. PFTs are essential for identifying patients with uncontrolled asthma. While abnormal radiological findings are common among asthma patients, they typically do not significantly impact management strategies. However, a chest X-ray is indispensable for excluding conditions such as pneumonia, pulmonary edema, and hyperinflation, which may necessitate a delay in surgery [96].

2) Management

Implementing a structured approach is advisable to ensure adequate disease management in asthma patients scheduled for surgery under general anesthesia (Table 5) [97,98]. It is crucial to optimize asthma control preoperatively to minimize the risk of PPCs. For patients with well-controlled asthma, continuing their inhaled controller therapy, including inhaled corticosteroid (ICS), is recommended.

In patients with uncontrolled asthma, it is advisable to defer surgery and focus on optimizing asthma management. If surgery cannot be postponed, initiating ICS and long-acting beta-agonists in previously untreated patients, increasing the ICS dose in those already receiving therapy, and using short-term oral corticosteroids to reduce airway inflammation can be effective in reducing PPCs. Several studies have supported the safety of perioperative short-term systemic glucocorticoid therapy in asthmatic patients [99].

In patients experiencing an acute exacerbation of symptoms, preoperative administration of 40 mg of oral methylprednisolone for 5 days has proven effective in reducing post-intubation wheezing. This is especially pertinent for newly diagnosed individuals or those exhibiting poor compliance with reversible airway obstruction [99]. For asthma patients previously prescribed systemic glucocorticoids within the last 6 months, maintaining adequate systemic levels throughout the perioperative period is recommended to decrease the risk of adrenal insufficiency. This may include intravenous administration of 100 mg of hydrocortisone every 8 hours or an equivalent dose.

Conclusion

A thorough preoperative assessment and management of patients with pulmonary conditions is crucial in minimizing the incidence of PPCs. Effective strategies entail risk stratification, optimal control of existing pulmonary diseases, and the implementation of preoperative interventions such as smoking cessation and respiratory rehabilitation. Further research is needed to refine these approaches and develop evidence-based guidelines for the perioperative care of patients at risk for PPCs.

Notes

Authors’ Contributions

Conceptualization: all authors. Methodology: all authors. Formal analysis: all authors. Data curation: all authors. Project administration: all authors. Visualization: all authors. Validation: Lee HW. Investigation: all authors. Writing - original draft preparation: all authors. Writing - review and editing: all authors. Approval of final manuscript: all authors.

Conflicts of Interest

Hyun Woo Lee is an early career editorial board member of the journal, but he was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.

Funding

No funding to declare.

Fig. 1.

Algorithm for the preoperative evaluation of patients undergoing non-thoracic surgery. Adapted from Diaz-Fuentes et al. [78] PPC: postoperative pulmonary complication; ARISCAT: Assess Respiratory Risk in Surgical Patients in Catalonia.

Fig. 2.

Evaluation for patients undergoing pulmonary resection. Adapted from Brunelli et al. [82], with permission from Elsevier. *High cardiac risk: (1) Newly diagnosed heart disease; (2) Heart disease requiring medication; (3) ThRCI (thoracic revised cardiac risk index) ≥2 points (where: pneumonectomy: 1.5 points; previous ischemic heart disease: 1.5 points; previous stroke or transient ischemic attack: 1.5 points; serum creatinine >2 mg/dL: 1 point); (4) Serum creatinine >2 mg/dL: 1 point; (5) Other factors such as comorbidities, age, surgical approach (thoracotomy vs. minimally invasive) and center experience. ppo: predicted postoperative; FEV₁ : forced expiratory volume in 1 second; DL_CO : diffusing capacity of the lungs for carbon monoxide; VO₂ max: maximal oxygen consumption; SCT: stair climb test; SWT: shuttle walk test.

Fig. 3.

Algorithm for general preoperative management. Adapted from Tuna et al. [42] COPD: chronic obstructive pulmonary disease; PPC: postoperative pulmonary complication.

Fig. 4.

Algorithm for the perioperative management of patients with chronic obstructive pulmonary disease (COPD). Adapted from Diaz-Fuentes et al. [78] ICU: intensive care unit; NIPPV: non-invasive positive pressure ventilation.

Table 1.

European Perioperative Clinical Outcome definitions for postoperative pulmonary complications [7]

Complication	EPCO definition
Respiratory infection	The patient has been treated with antibiotics for a suspected respiratory infection, meeting one or more of the following criteria: new or altered sputum, new or changed lung opacities, fever, or a white blood cell count exceeding 12×10⁹/L.
Respiratory failure	Postoperative PaO₂ levels below 8 kPa (60 mm Hg) on room air, a PaO₂:FiO₂ ratio under 40 kPa (300 mm Hg), or arterial oxyhemoglobin saturation measured by pulse oximetry below 90%, necessitating oxygen therapy.
Pleural effusion	Chest radiographs showing blunting of the costophrenic angle, obscured silhouette of the ipsilateral hemidiaphragm in an upright position, displacement of adjacent anatomical structures, or (in a supine position) a hazy opacity in one hemithorax with preserved vascular markings.
Atelectasis	Lung opacification leading to a shift of the mediastinum, hilum, or hemidiaphragm towards the affected area, accompanied by compensatory hyperinflation in the adjacent non-atelectatic lung.
Pneumothorax	Presence of air in the pleural space without a surrounding vascular bed on the visceral pleura.
Bronchospasm	Newly identified expiratory wheezing managed with bronchodilators.
Aspiration pneumonitis	Acute lung injury following inhalation of regurgitated gastric contents.
Pneumonia	CXR with at least one of the following: infiltrate, consolidation, cavitation; plus at least one of the following: fever >38°C without other causes, white cell count <4 or >12×10⁹ L, or >70 years of age with altered mental status without other causes; plus at least two of the following: new or changed purulent sputum, increased secretions/suctioning, new or worsened cough/dyspnea/tachypnoea, rales/bronchial breath sounds, or worsening gas exchange.

EPCO: European Perioperative Clinical Outcome; PaO₂: arterial oxygen partial pressure; FiO₂: fraction of inspired oxygen; CXR: chest X-ray.

Table 2.

Guidelines on preoperative pulmonary function tests and chest X-rays

Organization	Year	Recommendations
For preoperative pulmonary function tests
NICE [64]	2016	Do not routinely offer pulmonary function tests before minor surgeries
NICE [64]	2016	- Consider pulmonary function tests before intermediate or major surgeries if the ASA is ≥3 due to respiratory conditions
For preoperative chest X-rays
ASA [65]	2002	Consider chest radiography for:
		- Patients who smoke
		- History of recent upper respiratory infection with COPD
		- Patients with cardiac disease
		However, if these conditions are chronic and stable, preoperative chest radiography may not be indicated.
American College of Radiology [66]	2008	Chest radiography is usually appropriate for:
		- Patients exhibiting acute cardiopulmonary signs based on history or physical examination
		- Patients over 70 years with chronic cardiopulmonary disease who have not undergone chest radiography in the past 6 months
Institute for Clinical Systems Improvement [67]	2012	Chest radiography may be considered for patients exhibiting signs or symptoms suggestive of new or unstable cardiopulmonary disease.
NICE [64]	2016	Do not routinely offer chest X-rays before surgery.

NICE: National Institute for Health and Care Excellence; ASA: American Society of Anesthesiologists; COPD: Chronic Obstructive Pulmonary Disease.

Table 3.

Risk stratification of postoperative pulmonary complications [23,31,72,73]

Category	Arozullah respiratory failure index	Gupta calculator for postoperative respiratory failure	Gupta calculator for postoperative pneumonia	ARISCAT
Age	>70 (6 points), 60-69 (4 points)	-	Age×0.0144	≤50 (0 points), 51-80 (3 points), >80 (16 points)
Smoking	-	-	Smoking within last year: no (-0.4306), yes (0)	-
Preoperative factors	History of COPD: 6 points	-	COPD causing functional disability or hospitalization, or FEV₁ <75%: no (-0.4553), yes (0)	Preoperative SpO₂: ≥96% (0 points), 91-95% (8 points), ≤90% (24 points)
Functional status	Partially or fully dependent: 7 points	Independent (0), partially dependent (0.7678), totally dependent (1.4046)	Independent (0), partially dependent (0.7653), totally dependent (0.94)	-
ASA physical status	-	Healthy patient (-3.5265), mild disease (-2.0008), severe disease (-0.6201), life-threatening disease (0.2441), moribund (0)	Healthy patient (-3.0225), mild disease (-1.6057), severe disease (-0.4915), life-threatening disease (0.0123), moribund (0)	-
Previous respiratory infection	-	-	-	Respiratory infection in the past month: no (0 points), yes (17 points)
Type of surgery	Major vascular (27 points), thoracic (21 points), upper abdominal, neurosurgery, emergency (11-14 points)	Anorectal (-1.353), aortic (1.0781), bariatric (-1.0112), brain (0.7336), breast (-2.6462), cardiac (0.2744), ENT (except thyroid/parathyroid) (0.106), foregut or hepatopancreatobiliary (0.9694), gallbladder, appendix, adrenals, or spleen (-0.5668), hernia (ventral, inguinal, femoral) (0), intestinal (0.5737), neck (thyroid/parathyroid) (-0.5271), obstetric/gynecologic (-1.2431), orthopedic and non-vascular extremity (-0.8577), other abdominal (0.2416), peripheral vascular (-0.2389), skin (-0.3206), spine (-0.522), non-esophageal thoracic (0.6715), vein (-2.008), urology (0.3093)	Anorectal (-0.847), aortic (0.7178), bariatric (-0.6282), brain (0.6841), breast (-2.3318), cardiac (0.1382), ENT (except thyroid/parathyroid) (-0.3665), foregut or hepatopancreatobiliary (1.066), gallbladder, appendix, adrenals, or spleen (-0.3951), hernia (ventral, inguinal, femoral) (0), intestinal (0.6169), neck (-0.0872), obstetric/gynecologic (-0.4101), orthopedic (-0.5415), other abdomen (0.4021), peripheral vascular (-0.4519), skin (-0.5075), spine (-0.5672), non-esophageal thoracic (0.8901), vein (-1.476), urology (0.1076)	Peripheral (0 points), upper abdominal (15 points), intrathoracic (24 points)
Laboratory results	Albumin <3.0 g/dL (9 points), BUN >30 mg/dL (8 points)	-	-	Preoperative anemia (hemoglobin ≤10 g/dL): no (0 points), yes (11 points)
Sepsis	-	None (-0.784), preoperative systemic inflammatory response syndrome (0), preoperative sepsis (0.2752), preoperative septic shock (0.9035)	None (-0.7641), preoperative systemic inflammatory response syndrome (0), preoperative sepsis (-0.0842), preoperative septic shock (0.1048)	-
Emergency case	-	No (-0.5739), Yes (0)	-	No (0 points), yes (8 points)
Surgery duration	-	-	-	Duration of surgery (hr): ≤2 (0 points), 2-3 (16 points), >3 (23 points)

ASA classification: I (A normally healthy patient), II (A patient with mild systemic disease), III (A patient with systemic disease that is not incapacitating), IV (A patient with incapacitating systemic disease that is a constant threat to life), and V (A moribund patient who is not expected to survive for 24 hours with or without operation).

The risk of postoperative pulmonary complications is delineated by the Arozullah respiratory failure index, with class 1 (≤10 points) at 0.5%, class 2 (11-19 points) at 1.8%, class 3 (20-27 points) at 4.2%, class 4 (28-40 points) at 10.1%, and class 5 (>40 points) at 26.6%; as well as by the ARISCAT, with low risk (<26 points) at 1.6%, intermediate risk (26-44 points) at 13.3%, and high risk (≥45 points) at 42.1%.

ARISCAT: Assess Respiratory Risk in Surgical Patients in Catalonia; COPD: chronic obstructive pulmonary disease; FEV₁: forced expiratory volume in 1 second; SpO₂: oxygen saturation; ASA: American Society of Anesthesiologists; ENT: ear, nose, and throat; BUN: blood urea nitrogen.

Table 4.

Assessment of asthma control status

Clinical assessment	Well-controlled	Not well-controlled	Poorly controlled
Symptoms (wheezing, shortness of breath, chest tightness)	≤2 days/week	>2 days/week	Daily
Nighttime awakenings with breathing problems	≤2 times/month	3-4 times/month	>1 time/week
Short-acting beta-2 agonist use for rescue	≤2 days/week	>2 days/week but not daily	Daily
Interference with normal activity	None	Some limitation	Extreme limitation
Exacerbations requiring systemic corticosteroids	≤1 x/year	2-3 x/year	>3 x/year
Patients aged over 5 years
FEV₁ predicted	>80%	60%-80%	<60%
FEV₁/FVC	>0.8	0.75-0.80	<0.75

Adapted from Bayable et al. [94].

FEV₁: forced expiratory volume in 1 second; FVC: forced vital capacity.

Table 5.

Stepwise approach to the preoperative treatment of asthmatic patients based on their asthma control level

Degree of asthma control	Symptoms/Characteristics	Pharmacological intervention
Controlled asthma without ICS treatment	No current symptoms	Continue without medication
	No symptoms reported in the past 6 months	As needed, use low-dose ICS-formoterol or as needed, use low-dose ICS/SABA
	No history of drug use in the past 6 months
Asthma controlled with ICS treatment	No current symptoms	Continue controller therapy, including ICS or ICS/LABA
	No change in symptoms over the past 6 months
	History of ICS use
	Use of LABA
Asthma presenting recently developed symptoms	Recent symptoms following admission for surgery	Initiate ICS treatment
	History of using rescue SABA	Consider LABA
	No history of taking oral corticosteroids	Consider using SABA preoperatively if LABA is unavailable
	No history of taking oral corticosteroids	Administer OCS for 3-5 days preoperatively
Uncontrolled asthma	Daily symptoms of bronchial asthma	Increase ICS dosage with LABA as a controller
	Currently taking ICS/LABA	Consider using SABA preoperatively if LABA is unavailable
	Occupational or daily use of OCS	Consider biologic agents for uncontrolled patients with type 2 inflammation
	Occupational or daily use of OCS	Administer OCS for 3-5 days preoperatively
Acute exacerbation	Acute symptom flare-up	Initiate ICS administration via nebulizer
	Currently taking ICS/LABA, or without treatment	Begin administration of SABA and/or SAMA via nebulizer
		Increase the equivalent ICS dosage with LABA if currently using ICS/LABA
		OCS for 3-5 days preoperatively

Adapted from Bayable et al. [94].

ICS: inhaled corticosteroid; SABA: short-acting beta 2-agonist; LABA: long-acting beta 2-agonists; OCS: oral corticosteroid; SAMA: short-acting muscarinic antagonist.

References

1. Smetana GW, Conde MV. Preoperative pulmonary update. Clin Geriatr Med 2008;24:607-24.

2. Lawrence VA, Cornell JE, Smetana GW; American College of Physicians. Strategies to reduce postoperative pulmonary complications after noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006;144:596-608.

3. Yang CK, Teng A, Lee DY, Rose K. Pulmonary complications after major abdominal surgery: National Surgical Quality Improvement Program analysis. J Surg Res 2015;198:441-9.

4. Carey K, Stefos T, Shibei Zhao, Borzecki AM, Rosen AK. Excess costs attributable to postoperative complications. Med Care Res Rev 2011;68:490-503.

5. Bapoje SR, Whitaker JF, Schulz T, Chu ES, Albert RK. Preoperative evaluation of the patient with pulmonary disease. Chest 2007;132:1637-45.

6. Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth 2017;118:317-34.

7. Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol 2015;32:88-105.

8. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.

9. Fisher BW, Majumdar SR, McAlister FA. Predicting pulmonary complications after nonthoracic surgery: a systematic review of blinded studies. Am J Med 2002;112:219-25.

10. Agostini P, Cieslik H, Rathinam S, Bishay E, Kalkat MS, Rajesh PB, et al. Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors? Thorax 2010;65:815-8.

11. Song SW, Lee HS, Kim MS, Lee JM, Kim JH, Nam BH, et al. Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection. Ann Thorac Surg 2006;81:1974-81.

12. Bruells CS, Rossaint R. Physiology of gas exchange during anaesthesia. Eur J Anaesthesiol 2011;28:570-9.

13. Sweitzer BJ, Smetana GW. Identification and evaluation of the patient with lung disease. Anesthesiol Clin 2009;27:673-86.

14. Malbouisson LM, Humberto F, Rodrigues Rdos R, Carmona MJ, Auler JO. Atelectasis during anesthesia: pathophysiology and treatment. Rev Bras Anestesiol 2008;58:73-83.

15. Blum JM, Stentz MJ, Dechert R, Jewell E, Engoren M, Rosenberg AL, et al. Preoperative and intraoperative predictors of postoperative acute respiratory distress syndrome in a general surgical population. Anesthesiology 2013;118:19-29.

16. Smetana GW, Lawrence VA, Cornell JE; American College of Physicians. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006;144:581-95.

17. Fernandez-Bustamante A, Frendl G, Sprung J, Kor DJ, Subramaniam B, Martinez Ruiz R, et al. Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the perioperative research network investigators. JAMA Surg 2017;152:157-66.

18. Polanczyk CA, Marcantonio E, Goldman L, Rohde LE, Orav J, Mangione CM, et al. Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery. Ann Intern Med 2001;134:637-43.

19. Mills E, Eyawo O, Lockhart I, Kelly S, Wu P, Ebbert JO. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med 2011;124:144-54.e8.

20. Musallam KM, Rosendaal FR, Zaatari G, Soweid A, Hoballah JJ, Sfeir PM, et al. Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery. JAMA Surg 2013;148:755-62.

21. Wolters U, Wolf T, Stutzer H, Schroder T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996;77:217-22.

22. Bertorini TE. Perisurgical management of patients with neuromuscular disorders. Neurol Clin 2004;22:293-313.

23. Arozullah AM, Daley J, Henderson WG, Khuri SF. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. Ann Surg 2000;232:242-53.

24. Shin SH, Shin B, Kang D, Cho J, Kang HK, Chon HR, et al. Restrictive spirometric pattern and postoperative pulmonary complications following non-cardiothoracic surgery. Sci Rep 2019;9:12750.

25. Valentijn TM, Galal W, Hoeks SE, van Gestel YR, Verhagen HJ, Stolker RJ. Impact of obesity on postoperative and long-term outcomes in a general surgery population: a retrospective cohort study. World J Surg 2013;37:2561-8.

26. Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth 2018;121:706-21.

27. Gupta H, Ramanan B, Gupta PK, Fang X, Polich A, Modrykamien A, et al. Impact of COPD on postoperative outcomes: results from a national database. Chest 2013;143:1599-606.

28. van Ramshorst GH, Nieuwenhuizen J, Hop WC, Arends P, Boom J, Jeekel J, et al. Abdominal wound dehiscence in adults: development and validation of a risk model. World J Surg 2010;34:20-7.

29. Honma K, Tango Y, Honma K, Isomoto H. Perioperative management of severe interstitial pneumonia for rectal surgery: a case report. Kurume Med J 2007;54:85-8.

30. Fisher JH, Shapera S, To T, Marras TK, Gershon A, Dell S. Procedure volume and mortality after surgical lung biopsy in interstitial lung disease. Eur Respir J 2019;53:1801164.

31. Mazo V, Sabate S, Canet J, Gallart L, de Abreu MG, Belda J, et al. Prospective external validation of a predictive score for postoperative pulmonary complications. Anesthesiology 2014;121:219-31.

32. Ferguson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002;123:661-9.

33. Arozullah AM, Khuri SF, Henderson WG, Daley J; Participants in the National Veterans Affairs Surgical Quality Improvement Program. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 2001;135:847-57.

34. Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, Hert SD, et al. 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014;35:2383-431.

35. Berrisford R, Brunelli A, Rocco G, Treasure T, Utley M. The European Thoracic Surgery Database project: modelling the risk of in-hospital death following lung resection. Eur J Cardiothorac Surg 2005;28:306-11.

36. Fuster RG, Argudo JA, Albarova OG, Sos FH, Lopez SC, Codoner MB, et al. Prognostic value of chronic obstructive pulmonary disease in coronary artery bypass grafting. Eur J Cardiothorac Surg 2006;29:202-9.

37. Nicholson DJ, Kowalski SE, Hamilton GA, Meyers MP, Serrette C, Duke PC. Postoperative pulmonary function in coronary artery bypass graft surgery patients undergoing early tracheal extubation: a comparison between short-term mechanical ventilation and early extubation. J Cardiothorac Vasc Anesth 2002;16:27-31.

38. Canbaz S, Turgut N, Halici U, Balci K, Ege T, Duran E. Electrophysiological evaluation of phrenic nerve injury during cardiac surgery: a prospective, controlled, clinical study. BMC Surg 2004;4:2.

39. Medalion B, Katz MG, Cohen AJ, Hauptman E, Sasson L, Schachner A. Long-term beneficial effect of coronary artery bypass grafting in patients with COPD. Chest 2004;125:56-62.

40. Bailey SH, Bull DA, Harpole DH, Rentz JJ, Neumayer LA, Pappas TN, et al. Outcomes after esophagectomy: a tenyear prospective cohort. Ann Thorac Surg 2003;75:217-22.

41. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9.

42. Tuna ME, Akgun M. Preoperative pulmonary evaluation to prevent postoperative pulmonary complications. Anesthesiol Perioper Sci 2023;1:34.

43. Canet J, Gallart L, Gomar C, Paluzie G, Valles J, Castillo J, et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology 2010;113:1338-50.

44. Guay J, Choi P, Suresh S, Albert N, Kopp S, Pace NL. Neuraxial blockade for the prevention of postoperative mortality and major morbidity: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev 2014;2014:CD010108.

45. Hausman MS, Jewell ES, Engoren M. Regional versus general anesthesia in surgical patients with chronic obstructive pulmonary disease: does avoiding general anesthesia reduce the risk of postoperative complications? Anesth Analg 2015;120:1405-12.

46. Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert A, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000;321:1493.

47. Yamakage M, Kohro S, Yamauchi M, Namiki A. The effects of extracellular pH on intracellular pH, Ca2+ and tension of canine tracheal smooth muscle strips. Life Sci 1995;56:PL175-80.

48. Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders: first of two parts. N Engl J Med 1998;338:26-34.

49. Serpa Neto A, Hemmes SN, Barbas CS, Beiderlinden M, Biehl M, Binnekade JM, et al. Protective versus conventional ventilation for surgery: a systematic review and individual patient data meta-analysis. Anesthesiology 2015;123:66-78.

50. Ladha K, Vidal Melo MF, McLean DJ, Wanderer JP, Grabitz SD, Kurth T, et al. Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study. BMJ 2015;351:h3646.

51. Santer P, Wachtendorf LJ, Suleiman A, Houle TT, Fassbender P, Costa EL, et al. Mechanical power during general anesthesia and postoperative respiratory failure: a multicenter retrospective cohort study. Anesthesiology 2022;137:41-54.

52. Yamakage M, Iwasaki S, Namiki A. Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease. J Anesth 2008;22:412-28.

53. Hedenstierna G, Edmark L. Mechanisms of atelectasis in the perioperative period. Best Pract Res Clin Anaesthesiol 2010;24:157-69.

54. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications: a prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997;41:1095-103.

55. McLean DJ, Diaz-Gil D, Farhan HN, Ladha KS, Kurth T, Eikermann M. Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology 2015;122:1201-13.

56. Kirmeier E, Eriksson LI, Lewald H, Jonsson Fagerlund M, Hoeft A, Hollmann M, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. Lancet Respir Med 2019;7:129-40.

57. Naunheim KS, Wood DE, Krasna MJ, DeCamp MM, Ginsburg ME, McKenna RJ, et al. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg 2006;131:43-53.

58. Win T, Jackson A, Sharples L, Groves AM, Wells FC, Ritchie AJ, et al. Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J 2005;25:594-9.

59. McAlister FA, Khan NA, Straus SE, Papaioakim M, Fisher BW, Majumdar SR, et al. Accuracy of the preoperative assessment in predicting pulmonary risk after nonthoracic surgery. Am J Respir Crit Care Med 2003;167:741-4.

60. Lee HW, Lee JK, Oh SH, Kim DK, Chung HS, Heo EY. Effect of perioperative systemic steroid treatment on patients with obstructive lung disease undergoing elective abdominal surgery. Clin Respir J 2018;12:227-33.

61. Joo HS, Wong J, Naik VN, Savoldelli GL. The value of screening preoperative chest x-rays: a systematic review. Can J Anaesth 2005;52:568-74.

62. Archer C, Levy AR, McGregor M. Value of routine preoperative chest X-rays: a meta-analysis. Can J Anaesth 1993;40:1022-7.

63. Bouillot JL, Fingerhut A, Paquet JC, Hay JM, Coggia M. Are routine preoperative chest radiographs useful in general surgery? A prospective, multicentre study in 3959 patients. Association des Chirurgiens de l’Assistance Publique pour les Evaluations médicales. Eur J Surg 1996;162:597-604.

64. National Institute for Health and Care Excellence. Routine preoperative tests for elective surgery [Internet]. London: NICE; 2016 [cited 2024 Nov 19]. Available from: https://www.nice.org.uk/guidance/ng45/resources/routine-preoperative-tests-for-elective-surgery-pdf-1837454508997.

65. American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Practice advisory for preanesthesia evaluation: a report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology 2002;96:485-96.

66. Mohammed TLH, Kirsch J, Amorosa JK, Brown K, Chung JH, Dyer DS, et al. American College of Radiology Appropriateness Criteria: routine admission and preoperative chest radiography [Internet]. Reston: American College of Radiology; 2011 [cited 2024 Nov 19]. Available from: https://acsearch.acr.org/Files/DownloadFile?fileId=1072&filename=Routine20Admission20and20Preoperative20Chest20Radiography.pdf.

67. Danielson D, Bjork K, Card R, Foreman J, Harper C, Roemer R, et al. Preoperative evaluation [Internet]. Bloomington: Institute for Clinical Systems Improvement; 2012 [cited 2024 Nov 19]. Available from: https://www.icsi.org/guidelines_and_more/gl_os_prot/other_health_care_conditions/preoperative_evaluation/preoperative_evaluation_649.

68. Kansagra AJ, Stefan MS. Preoperative anemia: evaluation and treatment. Anesthesiol Clin 2016;34:127-41.

69. Unger EF, Thompson AM, Blank MJ, Temple R. Erythropoiesis-stimulating agents: time for a reevaluation. N Engl J Med 2010;362:189-92.

70. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011;378:1396-407.

71. Jeong BH, Shin B, Eom JS, Yoo H, Song W, Han S, et al. Development of a prediction rule for estimating postoperative pulmonary complications. PLoS One 2014;9:e113656.

72. Gallart L, Canet J. Post-operative pulmonary complications: understanding definitions and risk assessment. Best Pract Res Clin Anaesthesiol 2015;29:315-30.

73. Costescu F, Slinger P. Preoperative pulmonary evaluation. Curr Anesthesiol Rep 2018;8:52-8.

74. Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA, Smetana GW, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med 2006;144:575-80.

75. Arozullah AM, Conde MV, Lawrence VA. Preoperative evaluation for postoperative pulmonary complications. Med Clin North Am 2003;87:153-73.

76. Gupta H, Gupta PK, Fang X, Miller WJ, Cemaj S, Forse RA, et al. Development and validation of a risk calculator predicting postoperative respiratory failure. Chest 2011;140:1207-15.

77. Gupta H, Gupta PK, Schuller D, Fang X, Miller WJ, Modrykamien A, et al. Development and validation of a risk calculator for predicting postoperative pneumonia. Mayo Clin Proc 2013;88:1241-9.

78. Diaz-Fuentes G, Hashmi HR, Venkatram S. Perioperative evaluation of patients with pulmonary conditions undergoing non-cardiothoracic surgery. Health Serv Insights 2016;9(Suppl 1):9-23.

79. Mazzone P. Preoperative evaluation of the lung resection candidate. Cleve Clin J Med 2012;79 Electronic Suppl 1:eS17-22.

80. British Thoracic Society; Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001;56:89-108.

81. Brunelli A, Charloux A, Bolliger CT, Rocco G, Sculier JP, Varela G, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009;34:17-41.

82. Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e166S-90S.

83. Wong J, Lam DP, Abrishami A, Chan MT, Chung F. Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anaesth 2012;59:268-79.

84. Jamali S, Dagher M, Bilani N, Mailhac A, Habbal M, Zeineldine S, et al. The effect of preoperative pneumonia on postsurgical mortality and morbidity: a NSQIP analysis. World J Surg 2018;42:2763-72.

85. Lumb AB. Pre-operative respiratory optimisation: an expert review. Anaesthesia 2019;74 Suppl 1:43-8.

86. Boden I, Skinner EH, Browning L, Reeve J, Anderson L, Hill C, et al. Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial. BMJ 2018;360:j5916.

87. Katsura M, Kuriyama A, Takeshima T, Fukuhara S, Furukawa TA. Preoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgery. Cochrane Database Syst Rev 2015;2015:CD010356.

88. Benzo R, Wigle D, Novotny P, Wetzstein M, Nichols F, Shen RK, et al. Preoperative pulmonary rehabilitation before lung cancer resection: results from two randomized studies. Lung Cancer 2011;74:441-5.

89. Vagvolgyi A, Rozgonyi Z, Kerti M, Agathou G, Vadasz P, Varga J. Effectiveness of pulmonary rehabilitation and correlations in between functional parameters, extent of thoracic surgery and severity of post-operative complications: randomized clinical trial. J Thorac Dis 2018;10:3519-31.

90. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;130:2215-45.

91. Duggappa DR, Rao GV, Kannan S. Anaesthesia for patient with chronic obstructive pulmonary disease. Indian J Anaesth 2015;59:574-83.

92. Gualandro DM, Yu PC, Calderaro D, Marques AC, Pinho C, Caramelli B, et al. II Guidelines for perioperative evaluation of the Brazilian Society of Cardiology. Arq Bras Cardiol 2011;96(3 Suppl 1):1-68.

93. Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med 2006;100:1307-17.

94. Bayable SD, Melesse DY, Lema GF, Ahmed SA. Perioperative management of patients with asthma during elective surgery: a systematic review. Ann Med Surg (Lond) 2021;70:102874.

95. Lin CS, Chang CC, Yeh CC, Chung CL, Chen TL, Liao CC. Postoperative adverse outcomes in patients with asthma: a nationwide population-based cohort study. Medicine (Baltimore) 2016;95:e2548.

96. Applegate R, Lauer R, Lenart J, Gatling J, Vadi M. The perioperative management of asthma. J Allergy Ther 2013;1(S11):007.

97. Liccardi G, Salzillo A, Sofia M, D’Amato M, D’Amato G. Bronchial asthma. Curr Opin Anaesthesiol 2012;25:30-7.

98. Venkatesan P. 2023 GINA report for asthma. Lancet Respir Med 2023;11:589.

99. Silvanus MT, Groeben H, Peters J. Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasm after tracheal intubation. Anesthesiology 2004;100:1052-7.